< Back to latest news & events

News

HGF client SymPhysis Medical secures €2.2M to develop palliative care solutions

October 2024

Galway-based MedTech company, SymPhysis Medical, which develops patient-centred solutions in palliative care and focuses on digital catheter-based devices to treat fluid buildup in the body caused by late-stage cancers, has secured €2.2m in its latest funding round.

HGF manages all aspects of SymPhysis’s IP needs, with an emphasis on a strategy to ensure the IP supports the business so that they achieve not only the best protection of their IP, but also provide the best narrative to investors and potential buyers. As their business progresses along its journey from early-stage start-up to becoming commercial, the focus has been on building value in the company.  The HGF Team includes Craig Thomson, Jennifer Uno, Sean McDonagh, Alex Colman, David Akerman, and Jason Lessard.

A quote from Michelle Tierney, Co-Founder and CSO of Symphysis: “Prior to thinking about and developing our IP strategy with HGF, we were very much viewing our patent filings in isolation and not thinking strategically regarding how our patents may combine into a portfolio with other IP assets, and that we ensure we can be competitive in the eventual market we would commercialise. But even before commercialisation, thinking about how our IP may add value to the business in the short to medium term. For instance, by working with HGF we were able to pull together 2-3 year timelines regarding key upcoming events for the business, such a funding/investment rounds and conference attendances, so that we could consider timings for filings that lined up with communications we wanted to make re our IP to stakeholders for these events.”

The company is aiming to raise a total of €6.5m this year to fund ongoing expansion. Its next funding round is set to close at the end of the year.

For more information click here: https://www.symphysismedical.com/.

If you would like to invest in SymPhysis contact [email protected].

Latest updates

A leading case - beware sequence errors in patent claims

Samsung Bioepis UK Ltd v Alexion Pharmaceuticals Inc [2025] EWHC 1240 (Pat) – Mr Justice Meade – 20 May 2025 The UK Patents Court has held that Samsung Bioepis’ and Amgen’s …

Read article

ICELAND left out in the cold by the General Court

Earlier in the month, the EU General Court issued its decision on Iceland Foods Ltd’s appeal of a decision of the Grand Board of Appeal of EUIPO to invalidate an …

Read article

HGF recognised in Managing IP’s New “Trusted Talent” Table in Germany

We are proud to announce that HGF has been ranked in Managing IP’s newly launched Trusted Talent table in Germany, a recognition of our ongoing commitment to excellence in intellectual …

Read article

Briefing Note: UKIPO SEP Consultation

Overview and Strategic Context The UKIPO’s 2025 consultation on Standard Essential Patents (SEPs), announced on 15 July 2025, signals a potential policy shift in how the UK approaches SEP licensing …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

Quinas Technology Wins WIPO Global Award for Innovation in ICT

Our client, Quinas Technology, has been named the winner of the WIPO Global Award 2025 in the ICT Startup category. Quinas is a spin-out from Lancaster University. We have worked …

Read article

IP Ingredients: Summer Case Law Review 2025

As the British summer swings once again between sunburn and showers, it’s a great time to take stock of what the first half of the year has delivered by way …

Read article

Celebrating exam success at HGF!

We are once again delighted to share that our colleagues have achieved success in their recent exams! Their dedication, perseverance, and commitment to professional development have paid off, and we …

Read article